Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Sep 17, 2025 3:59:45 PM EDT

27.67USD+2.028%(+0.55)1,282,413

27.65Bid 27.69Ask 0.04Spread

Pre-market

Sep 17, 2025 9:16:30 AM EDT

27.25USD+0.479%(+0.13)4,839

After-hours

Sep 17, 2025 4:35:30 PM EDT

27.90USD+0.831%(+0.23)1,139

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

242.82M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Nov 10, 2025 (54d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

1,270,434

Avg. Vol. 30 Day

1,691,637

Employees

Market Cap

242,815,319

Shares Out.

8,765,896

On/Off Exchange

40%/60%

6 Month Beta

1.00

1 Year Beta

0.97

2 Year Beta

1.06

3 Year Beta

1.09

52 Week Low

6.76

52 Week High

130.00

SMA50

39.51

SMA200

28.36

1 Week

+2.63%

1 Month

-30.87%

3 Month

-20.68%

6 Month

+70.15%

1 Year

+88.44%

2 Year

-98.99%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $27.67, and today's volume is 1,282,413. TNXP is up 2.028% today. The 30 day average volume is 1,691,637. TNXP market cap is 242.82M with 8,765,896 shares outstanding.